Lucid Psychedelic Trips

Microdosing LSD vs. Psilocybin.  Microdosing is the practice of taking sub-perceptual amounts of   psychedelic substances   to gain therapeutic or performance-enhancing benefits without hallucinations. Typically, people microdose either LSD (lysergic acid diethylamide) or psilocybin (found in magic mushrooms). While both substances affect serotonin pathways in the brain, they offer distinct experiences, timelines, and benefits.   Microdosing LSD vs. Psilocybin LSD Microdosing: The Details LSD  is a synthetic psychedelic known for its long duration and clarity-enhancing effects. When microdosed (usually between 5–15 micrograms), LSD doesn’t cause hallucinations but may improve focus, creativity, energy, and overall mental clarity. Users often describe it as a “clean” experience, ideal for high-performance tasks. A typical microdosing schedule involves taking LSD every 3–4 days to avoid building tolerance. Psilocybin Microdosing: The Natural Approach Psilocybin ...

Exploring the Intersection of Neuroscience, Psychedelics, and Higher Education The field of  psychedelic studies  has undergone a profound transformation in recent years, moving from underground, countercultural roots to a rapidly growing academic discipline. With the increasing recognition of psychedelics’ potential therapeutic benefits, universities across the globe are embracing  psychedelic research  as a legitimate and exciting academic pursuit. In particular, the launch of the first-ever undergraduate degree in  psychedelic studies  at the  California Institute of Integral Studies  (CIIS)  is a groundbreaking moment for the industry, signaling a major shift in how psychedelics are understood, studied, and applied in both medical and social contexts. A New Academic Approach to Psychedelics In  August 2025 , CIIS in San Francisco will offer the United States’ first undergraduate degree program in  psychedelic studies . This pion...

Post-traumatic stress disorder (PTSD) and trauma-related conditions are on the rise, affecting millions worldwide. While traditional treatment methods such as psychotherapy and medication have been helpful for many, they are not always effective. As mental health challenges evolve, new approaches are emerging. One promising area of research is the use of psychedelics in treating trauma and PTSD. Substances like   MDMA ,   psilocybin   (magic mushrooms), and   ayahuasca   are gaining attention for their potential to aid in trauma healing. This article delves into how these psychedelics can transform the therapeutic landscape and offer a pathway to recovery. The Science of Psychedelics and Trauma Healing Psychedelics have long been known for their ability to alter consciousness and perception. Recent studies, however, reveal that these substances may hold significant therapeutic value, especially for individuals struggling with trauma and PTSD. Psychedelics intera...